Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to investigate if Mentalization-based therapy (MBT) is superior to enhanced usual care (treatment-as-usual-plus (TAU-plus)) for adolescents with disruptive behavior ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Hospital Heidelberg
Collaborators
NCT07456631 · Social Anxiety Disorder (SAD), Oppositional Defiant Disorder
NCT06831123 · Conduct Disorder, Oppositional Defiant Disorder
NCT07495683 · Behavioural Disorder, Disruptive Behavior Disorder, and more
NCT01822392 · Conduct Disorder, Oppositional Defiant Disorder
NCT07044609 · Attention-deficit/Hyperactivity Disorder, Oppositional Defiant Disorder in Children
Institut für Psychosoziale Prävention, Ruprecht-Karls-Universität Heidelberg
Heidelberg, Baden-Wurttemberg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions